Research & Education
Research is at the heart of the Vickie & Jack Farber Institute for Neuroscience at Jefferson, and it remains a crucial part of our mission. Each department carries out basic, translational, and clinical research designed to understand fundamental mechanisms of the normal and diseased brain. Our specialists translate that understanding into treatments for neurodegenerative and other devastating disorders.
Researchers at the institute share their findings and experiences with other academics and specialists from around the world and work together to treat, prevent, and find cures for all kinds of neurological and spine disorders, including new developments in thrombotic neurovascular disease in COVID-19.
This means more opportunities for NIH funding, new opportunities for research partnerships and sponsors, and ultimately, accelerated breakthroughs in the treatments of neurological disease.
Learn more about our research in each of the Farber Institute for Neuroscience departments:
Promising new advances are available right in our communities! Find out more about the latest clinical trials by visiting Abington-Jefferson Health Neurosciences Clinical Trials.
Jefferson Researchers Study How to Improve Mobility After Stroke
The Vickie and Jack Farber Institute for Neuroscience have initiated the Cortimo clinical trial, which uses microelectrodes in the brain and a robotically-powered brace to test a method that could one day restore parts of the body impaired by stroke.
The Annesley EyeBrain Center
Exploring the links between the eyes and the brain, the work and research done at the Annesley EyeBrain Center is truly groundbreaking in the fields of neuroscience and optometry.
COVID-19 Associated CNS Demyelinating Diseases
As the COVID-19 pandemic continues to reshape the world around us, Jefferson Health is making continuous advances when it comes to patient care. Jefferson is leading the way in our region for Coronavirus research, including new developments in thrombotic neurovascular disease in COVID-19 patients and COVID-19 among African Americans with diabetes, among other topics. Our efforts have been recognized by U.S. News & World Report as we continue to strive for providing the very best for our patients with complex conditions.